Abstract:High resolution human leukocyte antigen (HLA) typing is important in establishing eplet compatibility and the specificity of donor-specific anti-HLA antibodies (DSA). In deceased donor kidney transplantation, high resolution donor HLA typing may not be immediately available, leading to inaccuracies during the organ allocation process. We aimed to determine the concordance and agreement of HLA-Class I and II eplet mismatches calculated using population frequency based allelic haplotype association (linkage disequilibrium, LD) from sequence-specific oligonucleotide (SSO) and real-time polymerase chain reaction (rtPCR) donor HLA typing (available at time of donor kidney allocation) compared to high-resolution Next Generation Sequencing (NGS) donor typing. NGS high resolution HLA typing were available for all recipients prior to donor kidney allocation. A cohort of 94 deceased donor-recipient pairs from a single Western Australian center were included (77 individual donors typed, 55 local and 22 interstate). The number of class I (HLA-A+B+C) and class II (HLA-DRB1+DRB3/4/5+DQB1+DQA1+DPB1+DPA1) eplet mismatches were calculated using HLAMatchmaker, comparing LD- and NGS-HLA typing. The accuracy in assigning pre-transplant DSA was compared between methods. The concordance correlation coefficient (95%CI) for HLA-class I and II eplet mismatches were 0.994 (0.992 to 0.996) and 0.991 (0.986 to 0.993), respectively. The 95% limits of agreement for class I were -1.3 (-1.6 to -1.1) to 1.4 (1.2 to 1.7) and -4.8 (-5.7 to -3.9) to 5.0 (4.1 to 5.9) for Class II. Disagreement between the two methods were present for 11 and 37 of the Class I and II donor/recipient pairs. Of which, 5 had a difference of ≥5 class II eplet mismatches. There were 34 (36%) recipients with potential pre-transplant DSA, of which 8 (24% of recipients with DSA) had indeterminate and ultimately false positive DSA assigned by donor LD-typing. While the concordance between NGS- and LD-typing was high, the limits of agreement suggest meaningful differences between these two techniques. The inaccurate assignment of DSA from donor LD-typing may result in associated HLA being considered unacceptable mismatches, inappropriately precluding candidates' access to transplantation. Accurate imputation of two-field HLA alleles based on LD from SSO and rtPCR HLA typing remains a substantial challenge in clinical practice in-lieu of widely available, rapid, high-resolution methods.

Comparison of sequence-specific oligonucleotide probe vs next generation sequencing for HLA-A, B, C, DRB1, DRB3/B4/B5, DQA1, DQB1, DPA1, and DPB1 typing: Toward single-pass high-resolution HLA typing in support of solid organ and hematopoietic cell transplant programs

Application Of High-Throughput Next-Generation Sequencing For Hla Typing On Buccal Extracted Dna: Results From Over 10,000 Donor Recruitment Samples

The Accuracy of Sequence-Specific Oligonucleotide and Real-Time Polymerase Chain Reaction HLA Typing in Determining the Presence of Pre-Transplant Donor-Specific Anti-HLA Antibodies and Total Eplet Mismatches for Deceased Donor Kidney Transplantation

High-sensitivity HLA typing by Saturated Tiling Capture Sequencing (STC-Seq)

High resolution HLA genotyping with third generation sequencing technology-A multicentre study

Clinical Applicability of 2‐Field High‐Resolution and Extended HLA‐Allele Typing in Deceased Donor Kidney Allocation

Unambiguous Hla Genotyping Using Long-Range Pcr and Next-Generation Sequencing (ngs) on Buccal-Extracted Dna: Results from 4000 Donor Recruitment Samples.

Advancements in HLA Typing Techniques and Their Impact on Transplantation Medicine

Benchmarking freely available HLA typing algorithms across varying genes, coverages and typing resolutions

HLA genotyping in the clinical laboratory: comparison of next-generation sequencing methods

P011 Advances in HLA Clinical Relevant Exon Novelty Detection from over 21,000 Donor Recruitment Samples

P100: LONG RANGE NGS HLA TYPING IS ACCURATE IN THE IDENTIFICATION OF COMMON, RARE, AND NOVEL ALLELES

Revolutionising High Resolution HLA Genotyping for Transplant Assessment: Validation, Implementation and Challenges of Oxford Nanopore Technologies' Q20+ Sequencing

Next-generation Sequencing for HLA Typing of Class I Loci.

Application of High-Throughput, High-Resolution and Cost-Effective Next Generation Sequencing-Based Large-Scale Hla Typing in Donor Registry

Benchmarking the Human Leukocyte Antigen Typing Performance of Three Assays and Seven Next-Generation Sequencing-Based Algorithms

Impact of Previously Unrecognized HLA Mismatches Using Ultrahigh Resolution Typing in Unrelated Donor Hematopoietic Cell Transplantation

Concurrent use of two independent methods prevents erroneous HLA typing of deceased organ donors - An important strategy for patient safety and accurate virtual crossmatching for broader sharing

Development of a high-resolution mass-spectrometry-based method and software for human leukocyte antigen typing

Two‐field resolution on‐call HLA typing for deceased donors using nanopore sequencing

The Application of Low-Resolution and High-Resolution HLA Class II PCR-SSP Typing in Bone Marrow Transplantation